Published date: 31 October 2016

This notice was replaced on 31 October 2016

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Awarded contract (published 28 March 2017)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Demolition, site preparation and clearance work - 45111000

Location of contract

PR3 2JH

Value of contract

£600,000

Procurement reference

HCAP17068

Published date

31 October 2016

Closing date

28 November 2016

Contract start date

23 January 2017

Contract end date

29 May 2017

Contract type

Works

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

The Homes and Communities Agency wish to appoint a specialist contractor for treatment of contaminated ground at the Central Part of Area 4 at Whittingham Hospital.

The works include remediation of asbestos contaminated ground including disposal and reinstatement.

Note 16 November 2016 additional information has been added to the zip folder available via the link included.

More information

Attachments

Links

Additional text

The closing time for tenders is Monday 28th November 2016 at 13.00.

All discussions, meetings and communications will be conducted in English.

The contract will be subject to English law. Tenders and all supporting documents must be priced in GBP and all payments under the contract will be made in GBP.

Contractors must be licensed by the HSE and also be members of the Asbestos Removal Contractors Association (ARCA). In addition to ARCA we also recognise ACAD (Asbestos Control & Abatement Division).

This procurement and award is subject to the transparency arrangements being adopted by the UK Government. These arrangements include the publication of tender documentation issued by the HCA and the contract between the HCA and supplier. Bidders should highlight any areas they consider commercially sensitive in order for the HCA to be able to honour our transparency obligations without undermining the bidders commercial interests. Candidates are advised that the HCA is subject to the Freedom of Information Act 2000 ("The Act"). If a candidate considers that any of the information supplied as part of this procurement procedure should not be disclosed because of its commercial sensitivity, confidential or otherwise, they must, when providing this information, clearly identify the specific information they do not wish to be disclosed and clearly specify the reasons for its sensitivity. The HCA shall take such statements into consideration in the event that it receives a request pursuant to the Act which relates to the information provided by the interested party. Please note, it is insufficient to include a statement of confidentiality encompassing all the information provided in the response. The HCA takes a zero-tolerance approach to bribery and corruption and sets high standards of impartiality, integrity and objectivity in relation to the stewardship of public funds and the management of its activities. The principles contained within this policy apply to both internal and external audiences, including anyone wishing to undertake business or engage with the HCA. Please refer to our Anti-bribery and Corruption Policy by visiting https://www.gov.uk/government/publications/anti-bribery-and-corruption-policy for further information.

About the buyer

Contact name

Mark Phillips

Address

Level 1 A, City Tower
Piccadilly Plaza
Manchester
M1 4BT
England

Email

mark.phillips@hca.gsi.gov.uk